I
Ikhlas A. Khan
Researcher at University of Mississippi
Publications - 38
Citations - 659
Ikhlas A. Khan is an academic researcher from University of Mississippi. The author has contributed to research in topics: Glycoside & Matricaria chamomilla. The author has an hindex of 13, co-authored 38 publications receiving 494 citations. Previous affiliations of Ikhlas A. Khan include Soochow University (Suzhou) & King Saud University.
Papers
More filters
Journal ArticleDOI
Ursolic acid derivatives for pharmaceutical use: a patent review (2012-2016)
Hidayat Hussain,Ivan R. Green,Iftikhar Ali,Ikhlas A. Khan,Zulfiqar Ali,Abdullah M. Al-Sadi,Ishtiaq Ahmed +6 more
TL;DR: Ursolic acid has the potential to conjugate with other anticancer drugs or be transformed into its halo derivatives since this will greatly facilitate scientists to get lead compounds in cancer drug discovery.
Journal ArticleDOI
Quantitative Determination of Cannabinoids in Cannabis and Cannabis Products Using Ultra‐High‐Performance Supercritical Fluid Chromatography and Diode Array/Mass Spectrometric Detection
Mei Wang,Yan-Hong Wang,Bharathi Avula,Mohamed M. Radwan,Mohamed M. Radwan,Amira S. Wanas,Amira S. Wanas,Zlatko Mehmedic,John van Antwerp,Mahmoud A. ElSohly,Ikhlas A. Khan,Ikhlas A. Khan +11 more
TL;DR: The UHPSFC chromatographic separation of cannabinoids displayed an inverse elution order compared to UHPLC, and combined with PDA‐MS, this orthogonality is valuable for discrimination of cannabinoids in complex matrices.
Journal ArticleDOI
Therapeutic potential of boswellic acids: a patent review (1990-2015)
Hidayat Hussain,Ahmed Al-Harrasi,René Csuk,Umair Shamraiz,Ivan R. Green,Ishtiaq Ahmed,Ikhlas A. Khan,Zulfiqar Ali +7 more
TL;DR: BAs have the potential to form conjugates with other anticancer drugs that will synergistically enhance their anticancer effects; and it is believed that in order to get lead compounds, there needs to be a greater focus on the synthesis of halo derivatives of BAs.
Journal ArticleDOI
PXR mediated induction of CYP3A4, CYP1A2, and P-gp by Mitragyna speciosa and its alkaloids.
Vamshi K. Manda,Bharathi Avula,Olivia R. Dale,Zulfiqar Ali,Ikhlas A. Khan,Larry A. Walker,Shabana I. Khan +6 more
TL;DR: Results indicate that high consumption of Mitragyna speciosa extract along with the conventional drugs may lead to potential herb–drug interactions due to its effects on PXR.
Journal ArticleDOI
Variability in strength of red yeast rice supplements purchased from mainstream retailers
TL;DR: Despite FDA manufacturing standards, strength and composition of red yeast rice supplements sold at mainstream retail stores in the United States remains unpredictable.